240 related articles for article (PubMed ID: 33441752)
1. Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Sci Rep; 2021 Jan; 11(1):914. PubMed ID: 33441752
[TBL] [Abstract][Full Text] [Related]
2. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
4. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Gamper M; Viereck V; Eberhard J; Binder J; Moll C; Welter J; Moser R
Int Urogynecol J; 2013 Dec; 24(12):2049-57. PubMed ID: 23670165
[TBL] [Abstract][Full Text] [Related]
5. Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
Jiang YH; Jhang JF; Kuo HC
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626252
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Hsu YH; Kuo HC
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356
[TBL] [Abstract][Full Text] [Related]
7. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
8. Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.
Furuta A; Yamamoto T; Suzuki Y; Gotoh M; Egawa S; Yoshimura N
Int Urogynecol J; 2018 Jul; 29(7):961-966. PubMed ID: 29372285
[TBL] [Abstract][Full Text] [Related]
9. Urinary nerve growth factor correlates with the severity of urgency and pain.
Kim SW; Im YJ; Choi HC; Kang HJ; Kim JY; Kim JH
Int Urogynecol J; 2014 Nov; 25(11):1561-7. PubMed ID: 24866276
[TBL] [Abstract][Full Text] [Related]
10. Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Ho HC; Chiou DY; Kuo HC
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885006
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome.
Ke H; Zhu L; Wang Q; Xu K
BMC Urol; 2023 Nov; 23(1):180. PubMed ID: 37940904
[TBL] [Abstract][Full Text] [Related]
12. The Severity and Distribution of Nonurologic Pain and Urogenital Pain in Overactive Bladder are Intermediate Between Interstitial Cystitis and Controls.
Thu JHL; Vetter J; Lai HH
Urology; 2019 Aug; 130():59-64. PubMed ID: 31034917
[TBL] [Abstract][Full Text] [Related]
13. Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569430
[TBL] [Abstract][Full Text] [Related]
14. Perceptions of "urgency" in women with interstitial cystitis/bladder pain syndrome or overactive bladder.
Clemens JQ; Bogart LM; Liu K; Pham C; Suttorp M; Berry SH
Neurourol Urodyn; 2011 Mar; 30(3):402-5. PubMed ID: 21412821
[TBL] [Abstract][Full Text] [Related]
15. Assessment of bladder pressure and discomfort symptoms: How do overactive bladder differ from interstitial cystitis/bladder pain syndrome patients?
Gousse A; Vetter J; Lai HH
BMC Urol; 2023 Mar; 23(1):53. PubMed ID: 36997906
[TBL] [Abstract][Full Text] [Related]
16. Adverse Childhood Experiences in Women With Overactive Bladder or Interstitial Cystitis/Bladder Pain Syndrome.
Komesu YM; Petersen TR; Krantz TE; Ninivaggio CS; Jeppson PC; Meriwether KV; Dunivan GC
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e208-e214. PubMed ID: 33369968
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology, assessment, and treatment of overactive bladder symptoms in patients with interstitial cystitis/bladder pain syndrome.
Dobberfuhl AD
Neurourol Urodyn; 2022 Nov; 41(8):1958-1966. PubMed ID: 35607890
[TBL] [Abstract][Full Text] [Related]
18. A multiplexed analysis approach identifies new association of inflammatory proteins in patients with overactive bladder.
Ma E; Vetter J; Bliss L; Lai HH; Mysorekar IU; Jain S
Am J Physiol Renal Physiol; 2016 Jul; 311(1):F28-34. PubMed ID: 27029431
[TBL] [Abstract][Full Text] [Related]
19. Differences in Urodynamic Parameters Between Women With Interstitial Cystitis and/or Bladder Pain Syndrome and Severe Overactive Bladder.
Shim JS; Kang SG; Park JY; Bae JH; Kang SH; Park HS; Moon du G; Cheon J; Lee JG; Kim JJ; Oh MM
Urology; 2016 Aug; 94():64-9. PubMed ID: 27130264
[TBL] [Abstract][Full Text] [Related]
20. The misdiagnosis of interstitial cystitis/bladder pain syndrome in a VA population.
Skove SL; Howard LE; Senechal J; De Hoedt A; Bresee C; Cunningham TJ; Barbour KE; Kim J; Freedland SJ; Anger JT
Neurourol Urodyn; 2019 Sep; 38(7):1966-1972. PubMed ID: 31302944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
